Table 2.
Mouse lines with downstream disruption of GH action. Summary of the reported mouse lines with a disruption downstream of GHR that inhibits normal GH signaling. Selected phenotypes are included, such as serum GH and IGF-1 levels, body size and weight, bone growth, insulin sensitivity, reproductive capacity, and cancer incidence. Blank cells indicate parameters that were not reported.
| Mouse lines | GH level | IGF-1 level | Body size / Weight | Body composition | Bone growth | Insulin sensitivity | Reproductive capacity | Cancer incidence | Other notes | References |
|---|---|---|---|---|---|---|---|---|---|---|
| JAK2 KO | Lethal | Erythropoiesis impaired | [75] | |||||||
| STAT5b KO | ↑ (male only) | ↓ (both sexes) | ↓ (males only) | ↓ adipose tissue | ↓ (males only) | Poor lactation; deficient pregnancy | Varies by genetic background | Delay of hair growth; GH pulse-resistant | [69, 70, 76, 77] | |
| SOCS2 TG | ↑ | ↓ adipose tissue | Fertile | [71] | ||||||
| SOCS2 KO | ↑ local IGF-1; no difference in serum | ↑ | ↔ | ↑ | ↔ | Thickening of dermis; excessive collagen deposition | [78, 79] | |||
| ALS KO | ↔ | ↓ serum IGF-1 and IGFBP3 | ↓ | ↓ bone mineral density | ↔ | ↔ | [80, 81] | |||
| IGF-1 KO | Below detection limits | ↓ | ↓ | Infertile | High neonatal lethality (less than that of IGFR −/−), only 68% reach adulthood | [82, 83] | ||||
| IGFBP3-KO | ↔ | ↔; ↓ | No change at birth; ↑ overall weight | ↑ muscle mass; ↓ WAT mass | ↑ fasting blood glucose, ↑ insulin, impaired GTT | ↔ | ↑lung cancer progression | ↓ plasma TG adiponectin levels;↓ metabolic rate | [84–86] |